Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 9
2021 10
2022 26
2023 8
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Results by year
Filters applied: . Clear all
Page 1
Folate Receptor Beta for Macrophage Imaging in Rheumatoid Arthritis.
Steinz MM, Ezdoglian A, Khodadust F, Molthoff CFM, Srinivasarao M, Low PS, Zwezerijnen GJC, Yaqub M, Beaino W, Windhorst AD, Tas SW, Jansen G, van der Laken CJ. Steinz MM, et al. Among authors: zwezerijnen gjc. Front Immunol. 2022 Feb 2;13:819163. doi: 10.3389/fimmu.2022.819163. eCollection 2022. Front Immunol. 2022. PMID: 35185910 Free PMC article. Review.
Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index.
Mikhaeel NG, Heymans MW, Eertink JJ, de Vet HCW, Boellaard R, Dührsen U, Ceriani L, Schmitz C, Wiegers SE, Hüttmann A, Lugtenburg PJ, Zucca E, Zwezerijnen GJC, Hoekstra OS, Zijlstra JM, Barrington SF. Mikhaeel NG, et al. Among authors: zwezerijnen gjc. J Clin Oncol. 2022 Jul 20;40(21):2352-2360. doi: 10.1200/JCO.21.02063. Epub 2022 Mar 31. J Clin Oncol. 2022. PMID: 35357901 Free PMC article.
18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma.
Eertink JJ, van de Brug T, Wiegers SE, Zwezerijnen GJC, Pfaehler EAG, Lugtenburg PJ, van der Holt B, de Vet HCW, Hoekstra OS, Boellaard R, Zijlstra JM. Eertink JJ, et al. Among authors: zwezerijnen gjc. Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):932-942. doi: 10.1007/s00259-021-05480-3. Epub 2021 Aug 18. Eur J Nucl Med Mol Imaging. 2022. PMID: 34405277 Free PMC article.
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial.
Boni V, Fidler MJ, Arkenau HT, Spira A, Meric-Bernstam F, Uboha N, Sanborn RE, Sweis RF, LoRusso P, Nagasaka M, Garcia-Corbacho J, Jalal S, Harding JJ, Kim SK, Miedema IHC, Vugts DJ, Huisman MC, Zwezerijnen GJC, van Dongen GAMS, Menke van der Houven van Oordt CW, Wang S, Dang T, Zein IA, Vasiljeva O, Lyman SK, Paton V, Hannah A, Liu JF. Boni V, et al. Among authors: zwezerijnen gjc. Clin Cancer Res. 2022 May 13;28(10):2020-2029. doi: 10.1158/1078-0432.CCR-21-3656. Clin Cancer Res. 2022. PMID: 35165101 Free PMC article. Clinical Trial.
PET-CT Imaging of Polymeric Nanoparticle Tumor Accumulation in Patients.
Miedema IHC, Zwezerijnen GJC, Huisman MC, Doeleman E, Mathijssen RHJ, Lammers T, Hu Q, van Dongen GAMS, Rijcken CJF, Vugts DJ, Menke-van der Houven van Oordt CW. Miedema IHC, et al. Among authors: zwezerijnen gjc. Adv Mater. 2022 May;34(21):e2201043. doi: 10.1002/adma.202201043. Epub 2022 Apr 25. Adv Mater. 2022. PMID: 35427430
Blood-circulating EV-miRNAs, serum TARC, and quantitative FDG-PET features in classical Hodgkin lymphoma.
Drees EEE, Driessen J, Zwezerijnen GJC, Verkuijlen SAWM, Eertink JJ, van Eijndhoven MAJ, Groenewegen NJ, Vallés-Martí A, de Jong D, Boellaard R, de Vet HCW, Pegtel DM, Zijlstra JM. Drees EEE, et al. Among authors: zwezerijnen gjc. EJHaem. 2022 Apr 28;3(3):908-912. doi: 10.1002/jha2.432. eCollection 2022 Aug. EJHaem. 2022. PMID: 36051072 Free PMC article.
42 results